Clinical Trial Update: A Study of Guselkumab Administered Subcutaneously in Bio-naive Participants With Active Psoriatic Arthritis Axial Disease [Phase 4]

View source ↗

Summary

A Phase 4 study evaluating subcutaneous guselkumab in bio-naive participants with active psoriatic arthritis axial disease; the trial status is ACTIVE_NOT_RECRU…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriatic Arthritis

Drugs mentioned

• TREMFYA (guselkumab)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Arthritis, Psoriatic | Phase 4 | Status: ACTIVE_NOT_RECRUITING